Trend Analysis of Sexually Transmitted Infection Treatments in Korea-Reference-Cited by-同舟云学术

Trend Analysis of Sexually Transmitted Infection Treatments in Korea

Published:2024-08-31 Issue:2 Volume:19 Page:25-30
ISSN:2465-8243
Container-title:Urogenital Tract Infection
language:en
Short-container-title:Urogenit Tract Infect

Author:

Park Soeon¹^ORCID,Han Byung Kyu²^ORCID,Bae Sangrak³^ORCID,Lee Seung-Ju⁴^ORCID,Choi Jin Bong¹^ORCID

Affiliation:

1. Department of Urology, Bucheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea

2. Department of Urology, Perfect Urology Clinic, Seoul, Korea

3. Department of Urology, Uijeongbu St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea

4. Department of Urology, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea

Funder

KDCA

Publisher

Korean Association of Urogenital Tract Infection and Inflammation

Link

https://pdf.medrang.co.kr/UTI/2024/019/UTI019-02-01.pdf

Reference21 articles.

1. Korea Centers for Disease Control and Prevention (KCDC), Korean Association of Urogenital Tract Infection and Inflammation. Korean sexually transmitted infection guidelines. 2nd ed. KCDC; 2016.

2. Korea Disease Control and Prevention Agency (KDCA), Korean Association of Urogenital Tract Infection and Inflammation. Korean sexually transmitted infection guidelines. 3rd ed. KCDA; 2023.

3. Overall Low Extended-Spectrum Cephalosporin Resistance but high Azithromycin Resistance in Neisseria gonorrhoeae in 24 European Countries, 2015

4. Significant increase in azithromycin “resistance” and susceptibility to ceftriaxone and cefixime in Neisseria gonorrhoeae isolates in 26 European countries, 2019

5. Sustained transmission of high-level azithromycin-resistant Neisseria gonorrhoeae in England: an observational study